1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?

BACKGROUND: Vancomycin (VAN) combined with a β-lactam (COMBO) expedites MRSA bacteremia clearance compared with VAN alone. However, the impact of COMBO on persistent MRSA bacteremia (PB) using a contemporary definition of ≥5 days is unknown. There is also no consensus on which β-lactam (BL) should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Dilworth, Thomas J, Casapao, Anthony M, Ibrahim, Omar M, Jacobs, David M, Bowers, Dana R, Beyda, Nicholas D, Mercier, Renee-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253209/
http://dx.doi.org/10.1093/ofid/ofy210.903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253209/
http://dx.doi.org/10.1093/ofid/ofy210.903

Ejemplares similares